Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Nippon Kayaku Co.,Ltd.
ClinicalTrials.gov Identifier:
NCT01238952
First received: November 2, 2010
Last updated: November 12, 2014
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2013
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)